David J. Graham

8.2k total citations · 3 hit papers
115 papers, 5.6k citations indexed

About

David J. Graham is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David J. Graham has authored 115 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pharmacology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David J. Graham's work include Vestibular and auditory disorders (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). David J. Graham is often cited by papers focused on Vestibular and auditory disorders (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). David J. Graham collaborates with scholars based in United States, Canada and Thailand. David J. Graham's co-authors include Jeffrey A. Kelman, Thomas MaCurdy, Wayne A. Ray, David Campen, Michael Wernecke, Gerald Levy, Michele M. Spence, Rita L. Hui, Stanford Shoor and Craig Cheetham and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

David J. Graham

112 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

2005 683 citations David J. Graham, Wayne A. Ray et al. profile →
Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering Drugs

2004 649 citations David J. Graham profile →
Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

2014 498 citations David J. Graham, Marsha E. Reichman et al. Circulation profile →

Peers

Countries citing papers authored by David J. Graham

Since Specialization

Citations

This map shows the geographic impact of David J. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Graham more than expected).

Fields of papers citing papers by David J. Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Graham. The network helps show where David J. Graham may publish in the future.

Co-authorship network of co-authors of David J. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Graham. A scholar is included among the top collaborators of David J. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Graham. David J. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Opioid prescribing trends and pain scores among adult patients with cancer in a large health system 2025 ·Cancer ·(unknown), Pamela R. Soulos, Madhav KC, Molly M. Jeffery, Kathryn J. Ruddy, Catherine C. Lerro, Hana Lee, David J. Graham, Donna R. Rivera, (unknown), Michael Leapman, Vikram Jairam, Michaela A. Dinan, Cary P. Gross, Henry S. Park	1
2	Cannabis-Related Healthcare Encounters Among U.S. Commercially Insured Adults 2025 ·American Journal of Preventive Medicine ·Silvia Pérez-Vilar, Sruthi Adimadhyam, (unknown), (unknown), (unknown), (unknown), (unknown), Fatma M. Shebl, (unknown), (unknown), José J. Hernández‐Muñoz, Mayura Shinde, David J. Graham	0
3	Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease 2024 ·Journal of General Internal Medicine ·Silvia Pérez-Vilar, Andrew D. Mosholder, Elizabeth R. Smith, (unknown), (unknown), Marc B. Stone, (unknown), Yueqin Zhao, (unknown), Kira Leishear, Michael Wernecke, Thomas MaCurdy, Jeffrey A. Kelman, David J. Graham	1
4	Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017–2022 2024 ·American Journal of Public Health ·Silvia Pérez-Vilar, (unknown), (unknown), (unknown), Rose G. Radin, (unknown), (unknown), Michael Wernecke, Yoganand Chillarige, Jeffrey A. Kelman, David J. Graham	1
5	Trends in new and persistent opioid use in older adults with and without cancer 2023 ·JNCI Journal of the National Cancer Institute ·(unknown), Madhav KC, Pamela R. Soulos, Molly M. Jeffery, Kathryn J. Ruddy, Catherine C. Lerro, Hana Lee, David J. Graham, Donna R. Rivera, Michael Leapman, Vikram Jairam, Michaela A. Dinan, Cary P. Gross, Henry S. Park	3
6	Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies 2021 ·Pharmacoepidemiology and Drug Safety ·Vincent Lo Re, Dena M. Carbonari, Jerry Jacob, William R. Short, Charles E. Leonard, Jennifer G. Lyons, (unknown), (unknown), (unknown), Esther H. Zhou, David J. Graham, Cheryl N. McMahill‐Walraven, Lauren E. Parlett, Vinit Nair, Mano Selvan, Yunping Zhou, Gaia Pocobelli, Judith C. Maro, Michael Nguyen	18
7	Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation 2019 ·The American Journal of Medicine ·David J. Graham, (unknown), Rongmei Zhang, Jiemin Liao, Michael Wernecke, Marsha E. Reichman, Mao Hu, (unknown), Yuqin Wei, Margie R. Goulding, Yoganand Chillarige, Mary Southworth, Thomas MaCurdy, Jeffrey A. Kelman	98
8	Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation breakdown → 2014 ·Circulation ·David J. Graham, Marsha E. Reichman, Michael Wernecke, Rongmei Zhang, Mary Southworth, Mark Levenson, Ting-Chang Sheu, Katrina Mott, Margie R. Goulding, Monika Houstoun, Thomas MaCurdy, Chris Worrall, Jeffrey A. Kelman	498
9	Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs 2013 ·The American Journal of Medicine ·Daniel H. Solomon, Jeffrey R. Curtis, Kenneth G. Saag, Joyce Lii, Lang Chen, Leslie R. Harrold, Lisa J. Herrinton, David J. Graham, Mary K. Kowal, Bindee Kuriya, Liyan Liu, Marie R. Griffin, James D. Lewis, Jeremy A. Rassen	89
10	Neuropsychiatric events in varenicline and nicotine replacement patch users in the M ilitary H ealth S ystem 2012 ·Addiction ·Tamra E. Meyer, Lockwood G. Taylor, (unknown), David J. Graham, Andrew D. Mosholder, James R. Williams, David Moeny, Rita Ouellet‐Hellstrom, Trinka S. Coster	38
11	Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune‐mediated diseases 2012 ·Arthritis & Rheumatism ·Kevin Haynes, Timothy Beukelman, Jeffrey R. Curtis, Craig Newcomb, Lisa J. Herrinton, David J. Graham, Daniel H. Solomon, Marie R. Griffin, Lang Chen, Liyan Liu, Kenneth G. Saag, James D. Lewis	107
12	Heterogeneity of parvalbumin expression in the avian cerebellar cortex and comparisons with zebrin II 2011 ·Neuroscience ·Douglas R. Wylie, Cristián Gutiérrez‐Ibáñez, David J. Graham, (unknown), Janelle M.P. Pakan, Andrew N. Iwaniuk	10
13	Organization of visual mossy fiber projections and zebrin expression in the pigeon vestibulocerebellum 2009 ·The Journal of Comparative Neurology ·Janelle M.P. Pakan, David J. Graham, Douglas R. Wylie	39
14	Onset of acute myocardial infarction after use of non‐steroidal anti‐inflammatory drugs 2008 ·Pharmacoepidemiology and Drug Safety ·Tarek A. Hammad, David J. Graham, Judy A. Staffa, Cynthia Kornegay, Gerald J. Dal Pan	20
15	Early detection of adverse drug events within population‐based health networks: application of sequential testing methods 2007 ·Pharmacoepidemiology and Drug Safety ·Jeffrey S. Brown, Martin Kulldorff, K. Arnold Chan, Robert L. Davis, David J. Graham, (unknown), Susan E. Andrade, Marsha A. Raebel, Lisa J. Herrinton, Douglas W. Roblin, Denise M. Boudreau, David B. Smith, Jerry H. Gurwitz, Marc J. Gunter, Richard Platt	94
16	Impact of mailed warning to prescribers on the co‐prescription of tramadol and antidepressants 2004 ·Pharmacoepidemiology and Drug Safety ·Deborah Shatin, Jacqueline S. Gardner, Andy Stergachis, David K. Blough, David J. Graham	36
17	Troglitazone-induced liver failure: a case study 2003 ·The American Journal of Medicine ·David J. Graham, Lanh Green, John Senior, Parivash Nourjah	128
18	The risk of esophageal obstruction associated with an anti‐allergy medication (Claritin‐D® 24‐Hour—original formulation) 2003 ·Pharmacoepidemiology and Drug Safety ·(unknown), Carol R. Drinkard, Deborah Shatin, David J. Graham	1
19	COX‐2 selective non‐steroidal anti‐inflammatory drugs and cardiovascular disease 2002 ·Pharmacoepidemiology and Drug Safety ·Wayne A. Ray, Thomas M. MacDonald, Daniel H. Solomon, David J. Graham, Jerry Avorn	17
20	Tramadol and Seizures: A Surveillance Study in a Managed Care Population 2000 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Jacqueline S. Gardner, David K. Blough, Carol R. Drinkard, Deborah Shatin, Gail D. Anderson, David J. Graham, (unknown)	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact